XBiotech
XBIT
55 hedge funds and large institutions have $14.5M invested in XBiotech in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
4% more funds holding
Funds holding: 53 → 55 (+2)
0.79% less ownership
Funds ownership: 15.47% → 14.69% (-0.79%)
22% less capital invested
Capital invested by funds: $18.6M → $14.5M (-$4.12M)
59% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$60K |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$55.1K |
| 3 |
JP Morgan Chase
New York
|
+$53.7K |
| 4 |
IIM
INTECH Investment Management
West Palm Beach,
Florida
|
+$48.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$47.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$625K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$109K |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$77.9K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$74.5K |
| 5 |
Morgan Stanley
New York
|
-$58.2K |
XBIT Hedge Fund Activity: Q1 2025 in Review
55 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2025, worth a combined $14.5M — down 22% from $18.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new XBIT positions and 6 closed out — a net gain of 2 holders — while 9 added to existing stakes and 22 trimmed.
The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $60K. The largest seller was Millennium Management, cutting an estimated $625K.
- 55 institutional investors held XBiotech (XBIT) as of Q1 2025, up from 53 in Q4 2024.
- Funds reported $14.5M of XBiotech stock for Q1 2025, down 22% quarter-over-quarter.
- 8 funds opened new XBiotech positions in Q1 2025 and 6 closed out, a net change of +2 holders.
- The largest XBiotech buyer in Q1 2025 was Two Sigma Advisers, an estimated $60K added.
- The largest XBiotech seller in Q1 2025 was Millennium Management, an estimated $625K sold.
Based on aggregated 13F filings for Q1 2025.